198 related articles for article (PubMed ID: 18704915)
1. A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach.
Chen SY; Lin CH; Chang HM; Hsu HM; Yu JC
J Surg Oncol; 2008 Sep; 98(3):197-9. PubMed ID: 18704915
[TBL] [Abstract][Full Text] [Related]
2. Editorial regarding use of modified femoral vein approach as method for implanting a totally implantable access port in patients with synchronous bilateral mastectomies (Chen et al.).
Wanebo HJ
J Surg Oncol; 2008 Sep; 98(3):147. PubMed ID: 18704913
[No Abstract] [Full Text] [Related]
3. [Totally implantable venous access systems. Analysis of complications].
D'Angelo F; Ramacciato G; Caramitti A; Aurello P; Lauro S; Bordin F; Della Casa U
Minerva Chir; 1997; 52(7-8):937-42. PubMed ID: 9411296
[TBL] [Abstract][Full Text] [Related]
4. Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients.
Seiler CM; Frohlich BE; Dorsam UJ; Kienle P; Buchler MW; Knaebel HP
J Surg Oncol; 2006 Jan; 93(1):24-9. PubMed ID: 16353193
[TBL] [Abstract][Full Text] [Related]
5. Guidewire assisted cephalic vein cutdown for insertion of totally implantable access ports.
Chang HM; Hsieh HF; Hsu SD; Liao GS; Lin CH; Hsieh CB; Yu JC
J Surg Oncol; 2007 Feb; 95(2):156-7. PubMed ID: 17262733
[TBL] [Abstract][Full Text] [Related]
6. Use of a totally implantable access port through the external jugular vein when the cephalic vein approach is not feasible.
Lin YC; Chu CH; Ou KW; Chan DC; Hsieh CB; Chen TW; Hsu HM; Yu JC
Ann Vasc Surg; 2011 Feb; 25(2):217-21. PubMed ID: 20926248
[TBL] [Abstract][Full Text] [Related]
7. Trigger arrhythmia to confirm the position of totally implantable access ports (TIAP).
Hsieh HF; Yu JC; Chuang CH; Wu HS; Tsai YC; Lin CH
J Surg Oncol; 2007 Oct; 96(5):436-7. PubMed ID: 17372925
[TBL] [Abstract][Full Text] [Related]
8. [Totally implantable venous access ports by cephalic vein cut-down for patients receiving chemotherapy].
Ayadi S; Ksantini R; Maghrebi H; Daghfous A; Ayadi M; Fteriche F; Bedioui H; Chebbi F; Amous A; Jouini M; Kacem M; Mezlini A; Ben Safta Z
Tunis Med; 2011; 89(8-9):699-702. PubMed ID: 21948685
[TBL] [Abstract][Full Text] [Related]
9. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.
Ignatov A; Hoffman O; Smith B; Fahlke J; Peters B; Bischoff J; Costa SD
Eur J Surg Oncol; 2009 Mar; 35(3):241-6. PubMed ID: 18329836
[TBL] [Abstract][Full Text] [Related]
10. [Central venous totally implantable access for high dose chemotherapy in children].
Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
[TBL] [Abstract][Full Text] [Related]
11. Totally implantable femoral vein catheters in cancer patients.
Wolosker N; Yazbek G; Munia MA; Zerati AE; Langer M; Nishinari K
Eur J Surg Oncol; 2004 Sep; 30(7):771-5. PubMed ID: 15296992
[TBL] [Abstract][Full Text] [Related]
12. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
13. [Safety and effectiveness of central vein catheters indwelling with subcutaneous port in patients undergoing chemotherapy].
Ge F; Cang J; Xue ZG
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2331-4. PubMed ID: 19087693
[TBL] [Abstract][Full Text] [Related]
14. Low complication rates with totally implantable access port use in epoprostenol treatment of pulmonary hypertension.
Dickinson MG; Schölvinck EH; Boonstra A; Vonk-Noordegraaf A; Snijder RJ; Berger RM
J Heart Lung Transplant; 2009 Mar; 28(3):273-9. PubMed ID: 19285620
[TBL] [Abstract][Full Text] [Related]
15. External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement.
Di Carlo I; Barbagallo F; Toro A; Sofia M; Lombardo R; Cordio S
Ann Surg Oncol; 2005 Jul; 12(7):570-3. PubMed ID: 15889215
[TBL] [Abstract][Full Text] [Related]
16. Radiological and surgical placement of port devices: a 4-year institutional analysis of procedure performance, quality of life and cost in breast cancer patients.
Marcy PY; Magné N; Castadot P; Bailet C; Macchiavello JC; Namer M; Gallard JC
Breast Cancer Res Treat; 2005 Jul; 92(1):61-7. PubMed ID: 15980992
[TBL] [Abstract][Full Text] [Related]
17. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients.
Fischer L; Knebel P; Schröder S; Bruckner T; Diener MK; Hennes R; Buhl K; Schmied B; Seiler CM
Ann Surg Oncol; 2008 Apr; 15(4):1124-9. PubMed ID: 18214621
[TBL] [Abstract][Full Text] [Related]
18. Modification of approach for totally implantable venous access device decreases rate of complications.
Karanlik H; Kurul S
J Surg Oncol; 2009 Sep; 100(3):279-83. PubMed ID: 19582820
[TBL] [Abstract][Full Text] [Related]
19. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial infusion chemotherapy by the fixed-catheter-tip method: retrospective comparison of percutaneous left subclavian and femoral port-catheter system implantation.
Matsumoto T; Yamagami T; Yoshimatsu R; Morishita H; Kitamura N; Sato O; Hasebe T
AJR Am J Roentgenol; 2014 Jan; 202(1):211-5. PubMed ID: 24370146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
